Alternatives to Converge Bio

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

AI-driven digital twin of embryo development for cell-based therapies.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Alvox Bio is a life sciences startup developing novel therapeutic antibodies.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for designing novel molecular structures for new medicines.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

Drug discovery and development company using a novel technological approach.

Life science company pioneering drug discovery with AI and advanced technologies.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI platform for accelerating novel peptide therapeutic discovery and development.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

AI-driven predictive modeling company focused on biology and life sciences.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Unleashing the power of genomics at scale for biological advances and human health.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Building General Biological Intelligence

AI-enabled technology for cell biology research and biopharma development.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing novel therapeutics for rare genetic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Dot Compliance provides an AI-powered eQMS for life sciences companies to accelerate product delivery and reduce costs.

Advanced infectious disease diagnostics

VI Therapeutics is developing novel therapies for rare genetic diseases.

AI-powered platform accelerating biological research and drug discovery.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Synthetic biology platform for environmental sustainability solutions.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.